|
|
| Home | Stock Market Blogs | Financial Tools | Sign Up Free | |
| Biovest International, Inc. | |
||||||||||||||||||||||||||||||||||||||||||||||||
| Biovest International, Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BVTI | Last: $1.44 ($+0.09) | Volume: 40,726 | Last Trade: 8/5/2010 5:20:03 PM | ||||||||||||||||||||||||||||||||||||||||||||||
| Today
Today | Last 7 Days | 1 Month | 3 Month | 6 Month | 1 Year |
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Biovest International, Inc. Profile | |||||||||||||||||||||||||||||||||||||||||||||||||
| Biovest International is a biotechnology company focused on the development of BiovaxID , a patient-specific anti-cancer vaccine focusing on the treatment of follicular non-Hodgkins lymphoma, or follicular NHL. It has historically developed, manufactured and marketed patented cell culture systems and equipment to pharmaceutical, diagnostic and biotechnology companies, as well as research institutions worldwide, and has provided contract cell production services to those institutions. While continuing this business, management has chosen to re-orient Co.'s focus, assets and operations to increase contract cell production and biologic drug development and ownership. | |||||||||||||||||||||||||||||||||||||||||||||||||
| Biovest International, Inc. News & Press Releases | |||||||||||||||||||||||||||||||||||||||||||||||||
|
Accentia Biopharmaceutical's Revimmune Receives the Frost ... PR-Inside.com (Pressemitteilung): Accentia Biopharmaceutical's Revimmune Receives the Frost ... , Austria - Mar 17, 2008 Additionally, through an investment strategy, the Company has acquired the majority ownership interest in Biovest International, Inc. ( OTCBB:BV Accentia Biopharmaceutical's SinuNase Featured as ``Future ... PR-Inside.com (Pressemitteilung): Accentia Biopharmaceutical's SinuNase Featured as ``Future ... , Austria - Mar 15, 2008 Additionally, through an investment strategy, the Company has acquired the majority ownership interest in Biovest International, Inc. ( OTCBB:B Accentia Biopharmaceutical’s Revimmune Receives the Frost ... Business Wire (press release): Accentia Biopharmaceutical’s Revimmune Receives the Frost ... , CA - Mar 13, 2008 Additionally, through an investment strategy, the Company has acquired the majority ownership interest in Biovest International, Inc. ( OTCBB:BVTI ) and Businessnewsnow.us: Yesterdays Stock News Recap: ABPI, HMSY, CRMH ... Insurance News Net (press release): Businessnewsnow.us: Yesterdays Stock News Recap: ABPI, HMSY, CRMH ... , PA - Mar 12, 2008 Additionally, through an investment strategy, the Company has acquired the majority ownership interest in Biovest International, Inc. ( OTCBB:BVT |
|||||||||||||||||||||||||||||||||||||||||||||||||
| Home | Blogs | Savings Calculator | Tools | Contact Us | Disclosure | Site Map | Sign Up | Copyright © 2013 SmallCapWatch, LLC. |
| Never invest based soley on information from this website or our e-mail and IM alerts | |
